• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • ESC 2018 preview – Getting to the heart of Pfizer’s amyloidosis data evaluate
    August 21, 2018
    The most eagerly awaited data from this year’s European Society of Cardiology congress will involve Pfizer’s tafamidis, which has already scored a win in the Attr-act trial in cardiac amyloidosis. The questions now are around the size of the drug’s benefi

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service